BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 18 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 4,859,885 | $11,955,000 | 0.64% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $246,000 | 0.00% |
| Alyeska Investment Group, L.P. | 143,985 | $354,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31,792 | $78,000 | 0.00% |
| Geneva Advisors, LLC | 12,500 | $31,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $2,000 | 0.00% |
| MORGAN STANLEY | 500 | $1,000 | 0.00% |
| BlackRock Institutional Trust Company, N.A. | 28,379 | $70,000 | 0.00% |
| Walleye Trading LLC | 700 | $2,000 | 0.00% |
| LPL Financial LLC | 61,246 | $131,000 | 0.00% |